| Sign In to gain access to subscriptions and/or personal tools. |
Treatment of De Quervains Disease: Role of Conservative ManagementFrom the Department of Orthopaedic Surgery, Long Island Jewish Medical Center, Albert Einstein College of Medicine of Yeshiva University, New York and the Department of Orthopaedic Surgery, Hospital for Joint diseases/Orthopaedic Institute, New York University School of Medicine, New York, USA Correspondence: Dr Lewis B Lane, 800 Community Drive, Manhasset, New York 11030 USA., E-mail: handnwrist{at}aol.com This retrospective study compares two methods used to treat de Quervains disease: splintage with oral non-steroidal anti-inflammatory drugs (NSAIDs) and steroid injection. Patients were separated into three groups based on symptom severity: group I-minimal, group II-mild, and group III-moderate or severe. Three hundred and nineteen wrists in 300 patients were followed from one to six years. Fifteen of 17 patients with minimal symptoms were relieved with splintage and NSAIDs. However, only seven of 20 in Group II and two of eight in Group III treated similarly were relieved. Of the 249 patients in Group III treated with injections, 76% were completely relieved, 7% were improved, and 4% were not improved. We conclude that classification of patients with de Quervains disease based on their pre-treatment symptoms may assist surgeons in selecting the most efficacious treatment and in providing prognostic information to their patients.
Journal of Hand Surgery (British and European Volume), Vol. 26, No. 3,
258-260 (2001) This article has been cited by other articles:
|
||||||||||||||||
